Prognostic Role of Interferon ‐λ3 in Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis‐Associated Interstitial Lung Disease

ConclusionSerum IFN λ3 is a promising biomarker for identifying patients at high risk of poor outcomes in anti-MDA5 antibody–positive DM-ILD.

Source: Arthritis and Rheumatology - February 7, 2024 Category: Rheumatology Authors: Atsuki Fukada, Tomoyuki Fujisawa, Hironao Hozumi, Keigo Koda, Taisuke Akamatsu, Yoshiyuki Oyama, Yasuomi Satake, Mitsuru Niwa, Yusuke Kaida, Hiroyuki Matsuda, Koshi Yokomura, Naoki Koshimizu, Mikio Toyoshima, Shiro Imokawa, Dai Hashimoto, A Tags: Full Length Source Type: research